Glenmark Pharmaceuticals announced on Wednesday that the US FDA issued a Form 483 with five procedural observations after an inspection of its Monroe Manufacturing Facility in North Carolina...
.jpeg)
Syngene International shares are expected to be in focus after two major regulatory statements by the United States Food and Drug Administration (USFDA) on inspections at the company's Bengaluru-based facilities.
.jpeg)
The alarming surge in fake medicines detected across multiple Indian states has stimulated drug regulators to push for immediate, forceful intervention to protect public health and restore trust in the country’s pharmaceutical ecosystem.
.jpeg)
neSource Specialty Pharma Limited (BSE: 544292, NSE: ONESOURCE), a multi-modality specialty pharma pure-play CDMO, announced that its flagship facility in Bangalore, India.
 (1).png)
As a strategic enterprise to control antimicrobials' use in animals and include antimicrobial resistance (AMR), the Central Drugs Standard Control Organisation (CDSCO) will form a Joint Working Group.
 (1).png)
Bangalore District Chemists & Druggists Association (BDCDA) has urged the Karnataka state government to establish a high-level task force for enforcement
The introduction of Good Purchasing Practices (GPP) by the West Bengal Drugs Control Administration (WB DCA)
 (1).png)
The Central Drugs Standard Control Organisation (CDSCO) has uncovered a detailed guidance document focused on the safe disposal of unused and expired medicines.
The Indian pharmaceutical sector is rapidly adopting secure packaging, real-time verification, and digital authentication technologies
The National Accreditation Board for Hospitals and Healthcare Providers (NABH) has restated its zero-tolerance policy
, CDSCO.jpg)
